Edward T. Mathers - Sep 30, 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Stock symbol
OKUR
Transactions as of
Sep 30, 2025
Transactions value $
$0
Form type
4
Date filed
10/2/2025, 04:29 PM
Previous filing
Jul 2, 2025
Next filing
Oct 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mathers Edward T Director 104 5TH AVE, 19TH FLOOR, NEW YORK /s/ Zachary Bambach, attorney-in-fact 2025-10-02 0001328625

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OKUR Class A Common Stock Award $0 +4.13K +56.71% $0.00 11.4K Sep 30, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The RSUs were granted to the Reporting Person in lieu of a quarterly cash retainer, at the election of the Reporting Person, under the Issuer's Outside Director Compensation Policy.